Treatment of Hepatitis C with ledipasvir, sofosbuvir with or without ribavirin in post liver transplant patients in an academic center

被引：0
|
作者：
Pyrsopoulos, Nikolaos [1 ]
Lingiah, Vivek A. [1 ]
Sanaka, Sirish [1 ]
Fung, Phoenix [1 ]
Punnoose, Merlin [1 ]
机构：
[1] Univ Hosp, Liver Transplant, Newark, NJ USA
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1636
引用
收藏
页码：810A / 810A
页数：1
相关论文
共 50 条
  • [1] SAFETY AND TOLERABILITY OF RECURRENT HEPATITIS C TREATMENT IN POST LIVER AND LIVER/KIDNEY TRANSPLANT PATIENTS TREATED WITH LEDIPASVIR/SOFOSBUVIR WITH AND WITHOUT RIBAVIRIN OR SOFOSBUVIR WITH RIBAVIRIN: SINGLE CENTER EXPERIENCE
    Selim, K.
    Elhazin, B.
    Long, W.
    Karmanova, M.
    Salazar, J.
    Volk, M.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S788 - S789
  • [2] Sofosbuvir/Ledipasvir without Ribavirin is effective in the treatment of recurrent hepatitis C infection post liver transplant
    Shoreibah, Mohamed G.
    Jones, Deann
    Orr, Jordan
    Zhang, Jie
    Venkata, Krishna V.
    Massoud, Omar I.
    [J]. HEPATOLOGY, 2016, 64 : 995A - 996A
  • [3] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Mohamed Shoreibah
    Jordan Orr
    DeAnn Jones
    Jie Zhang
    Krishna Venkata
    Omar Massoud
    [J]. Hepatology International, 2017, 11 : 434 - 439
  • [4] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Shoreibah, Mohamed
    Orr, Jordan
    Jones, DeAnn
    Zhang, Jie
    Venkata, Krishna
    Massoud, Omar
    [J]. HEPATOLOGY INTERNATIONAL, 2017, 11 (05) : 434 - 439
  • [5] Outcome of Recurrent Hepatitis C Treatment in Post Liver and Liver/Kidney Transplant Patients Treated with Ledipasavir/Sofosbuvir with and without Ribavirin or Sofosbuvir with Ribavirin: Single Center Experience
    Selim, Khaled
    Elhazin, Bridgeida
    Long, Wen
    Salazar, Jennifer
    Karmanova, Marina
    Volk, Micheal
    [J]. TRANSPLANTATION, 2016, 100 : S124 - S124
  • [6] Treatment of recurrent Hepatitis C with sofosbuvir and simeprevir in post transplant patients in an academic liver center
    Pyrsopoulos, Nikolaos
    Okoronkwo, Nneoma O.
    Protopopas, George
    Rao, Kiran V.
    Lingiah, Vivek A.
    Ahmad, Maliha
    Bojito-Marrero, Lizza
    Ruping, Kathleen
    Edula, Raj
    [J]. HEPATOLOGY, 2015, 62 : 793A - 794A
  • [7] Post-Liver Transplant Treatment of Hepatitis C with a combination of Sofosbuvir, Simeprevir, ± Ribavirin at a High Volume Academic Transplant Center
    Ford, Ryan M.
    Pillai, Anjana
    Cheng, Nicole
    Young, Nikita M.
    Parekh, Samir
    Norvell, J. P.
    Subramanian, Ram
    Spivey, James
    [J]. HEPATOLOGY, 2014, 60 : 701A - 701A
  • [8] Ledipasvir and Sofosbuvir plus /- Ribavirin in Post-hepatic Transplant Patients Reinfected with Genotype 1 Hepatitis C at a Large Academic Medical Center
    Zachariah, Robin
    Badar, Muneer
    Venkat, Deepak
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1268 - S1268
  • [9] Effectiveness and safety of sofosbuvir/ledipasvir +/- ribavirin treatment in liver and/or renal transplant patients with chronic hepatitis C: A single-center experience
    Akin, Mete
    Buldukoglu, Osman Cagin
    Adanir, Haydar
    Suleymanlar, Inci
    Dincer, Dinc
    Yildirim, Bulent
    [J]. SAGE OPEN MEDICINE, 2018, 6
  • [10] Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin
    Pillai, A. A.
    Maheshwari, R.
    Vora, R.
    Norvell, J. P.
    Ford, R.
    Parekh, S.
    Cheng, N.
    Patel, A.
    Young, N.
    Spivey, J. R.
    Mgbemena, O.
    Wedd, J. P.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (11) : 1427 - 1432
12345